Heart Health Metrics Explained: What Your Wearable Data Actually Means (2026 Physician-Reviewed)

Heart health metrics are the five core data points measured by consumer wearables: resting heart rate (normal: 60–100 bpm), heart rate variability, ECG rhythm, blood pressure, and blood oxygen saturation (SpO₂, normal: 95–100%). Each metric reflects a different aspect of cardiovascular and autonomic nervous system function.

You just got a reading on your wearable that made you stop.

Maybe your heart rate was higher than you expected. Maybe your HRV dropped overnight and you have no idea why. Maybe your Apple Watch flagged an irregular rhythm — and now you’re staring at your phone, trying to decide if this is something to worry about.

This guide was written to answer exactly what you’re asking right now.

Reviewed by Dr. Rishav (M.B.B.S, PGD) — every threshold, every accuracy figure, and every “when to see a doctor” recommendation on this page reflects current clinical evidence, not content marketing.

Here’s what this guide covers:

• What each heart health metric actually measures — in plain language
• The exact normal ranges for your age, with reference tables
• How accurate your Apple Watch, Garmin, Fitbit, or Oura Ring actually is — by metric
• When to monitor at home, when to schedule a physician visit, and when to call 911

Start with your specific concern, or read through the full guide below.

Quick Reference: Normal Ranges at a Glance

Table values reflect American Heart Association guidelines. Wearable readings should be confirmed with clinical tools before any medical decision.

You can go back to: heart health monitoring overview , to learn overall heart health monitoring.

A normal resting heart rate for healthy adults is 60–100 beats per minute (bpm), according to the American Heart Association. Values consistently above 100 bpm at rest (tachycardia) or below 40 bpm with symptoms (bradycardia) warrant physician evaluation. Athletes may have resting heart rates as low as 40–55 bpm, which is normal and healthy.

Your resting heart rate (RHR) is the number of times your heart beats per minute when you’re at rest — not exercising, not anxious, not just finished with coffee.

A normal resting heart rate for adults, according to the American Heart Association, is 60–100 beats per minute (bpm). AHA guidance on resting heart rate (pulse)

That range is wider than most people expect. It accounts for natural variation across age, fitness level, medications, and body composition.

Normal Resting Heart Rate by Age

Source: American Heart Association. Athlete ranges reflect well-trained endurance athletes. Values represent resting, seated measurements, not activity-adjusted readings.

What a Heart Rate of 90 BPM at Rest Actually Means

A resting heart rate of 90 bpm falls within the technically normal range (60–100 bpm) — but it sits in the upper third, where the picture gets more nuanced.

Research consistently shows that resting heart rates above 80 bpm are associated with increased cardiovascular risk compared to rates in the 60–70 bpm range, even within the “normal” threshold.

A single reading of 90 bpm is not an emergency. A consistent resting HR of 90+ bpm over weeks or months — without a clear cause like recent illness, high caffeine intake, or intense exercise — is worth discussing with your physician.

Causes of a consistently elevated resting HR include: dehydration, anemia, thyroid dysfunction, anxiety disorders, stimulant medications, sleep apnea, and early cardiac conditions.

What to do: If your wearable consistently shows a resting HR above 90 bpm and you have no known cause, schedule a routine physician visit — not an emergency room visit, unless accompanied by chest pain, shortness of breath, or dizziness.

Tachycardia and Bradycardia: Wearable Thresholds vs. Clinical Definitions

Tachycardia is medically defined as a resting heart rate above 100 bpm. If your wearable consistently shows resting HR above 100 bpm and you are not ill, dehydrated, or anxious, physician evaluation is appropriate.

Bradycardia is medically defined as a resting heart rate below 60 bpm. In athletes and very fit individuals, a resting HR of 40–55 bpm is normal and healthy. In a non-athlete with no history of athletic training, a resting HR consistently below 55–60 bpm — particularly if accompanied by fatigue, lightheadedness, or shortness of breath — warrants physician evaluation.

When to seek emergency care: A heart rate above 150 bpm at rest with no clear exertion trigger, or below 40 bpm with symptoms (dizziness, fainting, shortness of breath), requires emergency evaluation.

How Medications Affect Your Wearable Heart Rate Readings

If you take beta-blockers (metoprolol, atenolol, propranolol), your resting heart rate will be pharmacologically reduced — often to 50–65 bpm. This is intended and does not indicate bradycardia. Do not use wearable HR data to adjust beta-blocker dosing without physician guidance.

If you take stimulant medications (ADHD medications, decongestants) or consume significant caffeine daily, your resting HR may be elevated 5–15 bpm above your natural baseline. This should be factored into your interpretation of wearable HR data.

If you have a cardiac pacemaker, your wearable HR reading reflects the paced rate — which may not align with what the pacemaker is programmed to deliver. Discuss wearable monitoring with your electrophysiologist.

Why Is My Heart Rate High? 4 Factors That Raise Your BPM

Heart rate is dynamic and responds to various internal and external stimuli. Factors observed in clinical studies to influence HR include:

View AHA guidance on resting heart rate (pulse)

What does your HRV score actually mean?

Heart rate variability (HRV) measures the millisecond-level variation between consecutive heartbeats. It’s one of the most clinically meaningful numbers your wearable tracks — and one of the most misunderstood.

A higher HRV reflects a well-recovered, stress-resilient autonomic nervous system (ANS). A low or suddenly dropping HRV — common after alcohol consumption, poor sleep, or the early stages of illness — signals that your body is under physiological strain.

The key insight: a single low HRV reading is rarely concerning. A sustained decline over 3–5 days is when you should pay attention.

Wearables measure HRV using photoplethysmography (PPG) — the optical sensor on the back of your device that detects blood volume changes under your skin.

Most consumer devices report HRV as RMSSD (root mean square of successive differences), measured in milliseconds. This is the most widely validated HRV metric in clinical and research settings.

View Harvard Health: heart rate variability and well-being

View Mayo Clinic: blood pressure chart and interpretation

HRV Normal Range by Age and Fitness Level

HRV declines naturally with age. These population averages are drawn from wearable and clinical research. Your personal baseline — tracked over time — matters more than any single reading.

A healthy HRV (measured as RMSSD) for adults aged 30–39 typically falls between 35–75 ms. Adults aged 50–59 commonly see values of 20–55 ms. HRV declines naturally with age, and personal baseline trends over time are more clinically meaningful than any single absolute reading.

These ranges apply to adults at rest. Athletes typically show HRV values 20–30% above age-matched population averages. Readings vary by device — see the device accuracy section below.

What a Sudden Drop in HRV Means

A single-night HRV drop is almost always explainable. The most common triggers:

• Alcohol: Even moderate drinking (1–2 drinks) suppresses HRV for 12–24 hours
• Illness: HRV often drops 1–3 days before overt symptoms appear — it’s one of the earliest physiological warning signals your wearable can detect
• Poor sleep: Short or fragmented sleep reduces parasympathetic activity, which directly lowers HRV
• Overtraining: Back-to-back high-intensity exercise sessions without recovery will compress HRV
• Psychological stress: Acute emotional stress triggers the same sympathetic response as physical stress

If your HRV has dropped and stayed low for more than 3–5 consecutive days without a clear lifestyle explanation, that warrants a conversation with your physician — particularly if you also have elevated resting heart rate, fatigue, or chest discomfort.

How Apple Watch, Garmin, and Oura Measure HRV Differently

Not all wearables measure HRV the same way — and the differences matter.

Apple Watch measures HRV during sleep using PPG, reporting RMSSD in the Health app. It captures a 1-minute window during the night, which means your reading reflects a snapshot rather than a full-night average.

Garmin devices (Fenix, Venu series) measure HRV overnight using continuous PPG tracking and report a 5-day average, which smooths out single-night variability. Garmin also offers HRV Status — a relative indicator rather than a raw RMSSD value.

Oura Ring measures HRV during the lowest point of sleep (typically deep sleep), then reports RMSSD as part of its Readiness Score. Because Oura captures the most physiologically stable measurement window, its readings tend to be more consistent than wrist-based devices.

Key takeaway: Comparing HRV numbers between devices is not clinically meaningful. Track trends within a single device only.

Find the right device for tracking HRV

Can a smartwatch actually detect AFib — and should you trust the result?

Consumer wearable ECGs that have received FDA 510(k) clearance have demonstrated sensitivity of 85–99% and specificity of 91–100% for detecting atrial fibrillation (AFib) in peer-reviewed validation studies. Those are clinically meaningful numbers.

However, they come with a critical condition: these figures apply only to stationary, artifact-free single-lead recordings captured under ideal conditions.

Your Apple Watch ECG and a clinical 12-lead ECG are fundamentally different tools. Here is exactly what each can and cannot do.

Wearable ECG vs. 12-Lead Clinical ECG: Key Limitations

Consumer wearable ECGs with FDA 510(k) clearance have demonstrated 85–99% sensitivity and 91–100% specificity for detecting atrial fibrillation (AFib) in peer-reviewed validation studies. These figures apply to stationary, artifact-free single-lead recordings — and do not reflect the accuracy of a clinical 12-lead ECG evaluation.

What your wearable ECG can reliably do: Flag irregular rhythm patterns consistent with AFib, prompting a follow-up with a cardiologist.

What it cannot do: Confirm or rule out AFib with the certainty of a clinical evaluation, diagnose most other arrhythmias, or detect structural heart abnormalities.

What an Inconclusive ECG Result Means — and What to Do

An “inconclusive” result is one of the most common — and least explained — wearable ECG outcomes. It does not mean something is wrong with your heart. It means the device could not capture a clean enough recording to classify the rhythm.

Common causes of an inconclusive result:

• Movement artifact: Even slight wrist movement during the 30-second recording contaminates the signal
• Poor skin contact: Dry skin, lotion, or an improperly positioned watch reduces electrode contact quality
• Unclassifiable rhythm: Some normal rhythm variants fall outside the classification parameters of single-lead consumer ECG algorithms
• Low heart rate during recording: Very low resting heart rates can produce borderline algorithmic outputs

What to do with an inconclusive result:

If the result remains inconclusive after 2–3 attempts and you have accompanying symptoms (palpitations, chest discomfort, dizziness), contact your physician — do not attempt to self-diagnose from repeated inconclusive recordings

Sit still in a relaxed position, rest your arm on a flat surface, and repeat the recording

Ensure the watch band is snug and the device is clean and dry

Sensitivity and Specificity of AFib Detection on Consumer Wearables

The two most important accuracy measures for any diagnostic tool are sensitivity (the ability to correctly identify AFib when it is present) and specificity (the ability to correctly identify normal rhythm when AFib is not present).

For FDA-cleared consumer wearable ECGs:

• Sensitivity: 85–99% — meaning 1–15 of every 100 true AFib cases may be missed
• Specificity: 91–100% — meaning up to 9 of every 100 normal readings may be flagged as a potential AFib alert when none is present

What this means in practice: A positive AFib alert on your wearable is a significant prompt for clinical evaluation — not a diagnosis. A negative result (normal sinus rhythm) does not rule out intermittent AFib, which may not occur during the 30-second recording window.

What FDA 510(k) Clearance Actually Means for Consumers

The FDA 510(k) pathway clears a device as “substantially equivalent” to an already-cleared predicate device. It is not the same as FDA approval, and it does not mean the device has been proven to perform as accurately as a clinical ECG.

For wearable ECGs, 510(k) clearance means:

• The device has demonstrated adequate performance for detecting AFib in a specific test population
• It has been cleared for consumer use as a screening tool, not a diagnostic tool
• It should be used to prompt clinical follow-up, not replace it

Devices with FDA 510(k) clearance for ECG/AFib detection (as of 2026) include Apple Watch Series 4 and later, Kardia Mobile (AliveCor), and select Samsung Galaxy Watch models. Always verify current clearance status on the FDA’s 510(k) database.

See best devices for ECG monitoring

Limitations of Consumer ECG Devices

It is critical to note that consumer ECG wearables:

Cannot detect a heart attack (myocardial infarction).
May produce “inconclusive” results if the heart rate is above 100 or below 50 bpm.
Are susceptible to “noise” from electrical interference or poor skin contact.

The honest answer: for most people, not yet — not with the accuracy required for hypertension management.

Most wearables that include a blood pressure feature use optical PPG estimation. The device detects pulse wave characteristics and uses an algorithm to estimate systolic and diastolic pressure.

This approach is fundamentally different from the cuff-based occlusion method that clinical and home blood pressure monitors use — and the accuracy gap is clinically significant.

Optical BP Estimation vs. Cuff-Based Measurement: Accuracy Comparison

Wearable blood pressure monitors that use optical PPG estimation — including most Apple Watch and Samsung Galaxy Watch models — have not demonstrated clinical equivalence to validated cuff-based devices. The American Heart Association does not currently recommend standalone wearable blood pressure readings for hypertension diagnosis or management.

The American Heart Association does not currently recommend standalone wearable blood pressure readings for hypertension diagnosis or management. Use a validated cuff-based device for any medical decision related to blood pressure.

AHA Blood Pressure Categories and What They Mean

Blood pressure categories established by the American Heart Association:

Source: American Heart Association, 2017 Hypertension Guidelines (updated guidance consistent as of 2026)

Note on wearable readings: Because wearable optical BP estimation carries a ±10–15 mmHg error margin, a Stage 1 or Elevated reading from a wearable should be confirmed with a validated cuff-based device before taking any action.

A Hypertensive Crisis reading from a wearable — particularly if you have no symptoms — should still be confirmed promptly, but do not delay seeking care if you have accompanying headache, chest pain, vision changes, or shortness of breath.

According to the American Heart Association (AHA) and American College of Cardiology (ACC):

View (AHA: Understanding blood pressure readings)

Which Wearables Have FDA-Cleared Blood Pressure Features?

As of 2026, FDA clearance for wearable blood pressure monitoring remains limited.

The Samsung Galaxy Watch series received clearance for blood pressure monitoring in certain markets, but this feature requires periodic calibration against a cuff-based device and should not be used as a standalone diagnostic tool.

Apple Watch does not currently have FDA clearance for blood pressure measurement.

Garmin and Fitbit devices with optical BP features are classified as wellness tools, not medical devices.

Always check the FDA’s 510(k) clearance database for current device status, as approvals in this category are evolving rapidly.

Should You Use a Smartwatch for Hypertension Management?

As a trend tracker, yes — with caveats. If you are being treated for hypertension and want to monitor between physician visits, a wearable can help you identify patterns (post-exercise spikes, morning readings, stress-related increases).

As your primary BP monitoring tool, no — the accuracy margin is too wide for medication titration or clinical decision-making.

For hypertension management, the American Heart Association recommends a validated upper-arm cuff monitor, taken in the morning before medication and in the evening, following the standard protocol (seated, rested, arm supported at heart level).

⚠️ When to See a Doctor About Heart Rate, HRV, or ECG Readings

While wearables provide valuable insights into your physiological trends, they are not diagnostic tools and should not replace professional medical evaluation.

You should consult a healthcare provider immediately if you experience any of the following symptoms, regardless of what your device data indicates:

* Persistent Chest Pain: Any pressure, squeezing, or discomfort in the chest area.
* Unexplained Shortness of Breath: Difficulty breathing during rest or light activity.
* Fainting or Severe Dizziness: Any loss of consciousness or feeling of lightheadedness.
* Consistent Tachycardia or Bradycardia: A resting heart rate consistently above 100 bpm (when is heart rate dangerously high) or below 40 bpm (without athletic training).
* Symptomatic Arrhythmia: Palpitations or a “fluttering” feeling in the chest, especially if accompanied by an irregular rhythm notification from your device

View the AHA Clinical Guidelines for Heart Rate and Blood Pressure

SpO₂ (oxygen saturation) measures the percentage of hemoglobin in your blood that’s carrying oxygen. A normal SpO₂ reading for a healthy adult is 95–100%. Readings below 95% are worth noting. Readings below 90% — particularly if sustained — warrant prompt medical attention.

Wearables measure SpO₂ using photoplethysmography (PPG): the device emits light into your skin and measures how much is absorbed by oxygenated vs. deoxygenated blood. It’s the same principle as the clip-on pulse oximeter a nurse might use — but with meaningful differences in accuracy.

Normal SpO₂ Range and What Readings Below 90% Mean

These thresholds apply at sea level. SpO₂ readings are naturally lower at altitude — consult your physician for altitude-adjusted reference values.

FDA: pulse oximeter basics

Why SpO₂ Accuracy Varies by Skin Tone — and What That Means for Your Reading

This is one of the most clinically important limitations of wearable SpO₂ sensors — and one of the least communicated.

Wearable PPG sensors emit light (typically red and infrared wavelengths) into the skin and measure the reflected signal. Higher concentrations of melanin absorb more of that light, interfering with the sensor’s ability to accurately distinguish oxygenated from deoxygenated blood.

Research published in the New England Journal of Medicine found that pulse oximeters — including wearable PPG sensors — overestimate SpO₂ values in individuals with darker skin tones by an average of 2–4 percentage points. In practical terms:

• A reading of 94% on a wearable could represent a true SpO₂ closer to 90–92% in individuals with higher melanin concentrations
• A reading of 92% could reflect clinical hypoxia even though the device doesn’t flag it as dangerous

What to do with this information: If your wearable shows a borderline SpO₂ reading between 92–96% and you have a darker skin tone, treat the number as a potential underread. Confirm with a clinical-grade pulse oximeter (available at most pharmacies) or consult your physician rather than relying on the wearable reading alone.

This limitation is not unique to any one brand — it affects PPG-based SpO₂ measurement across Apple Watch, Fitbit, Garmin, and Oura Ring.

SpO₂ Below 90% During Sleep: What Your Wearable Is Detecting

SpO₂ below 90% for more than 5 consecutive minutes during sleep may indicate sleep-disordered breathing or hypoxia and warrants medical evaluation. Wearable SpO₂ readings should be confirmed with a clinical pulse oximeter before any medical decision is made.

What to do with this information: If your wearable shows a borderline SpO₂ reading between 92–96% and you have a darker skin tone, treat the number as a potential underread. Confirm with a clinical-grade pulse oximeter (available at most pharmacies) or consult your physician rather than relying on the wearable reading alone.

This limitation is not unique to any one brand — it affects PPG-based SpO₂ measurement across Apple Watch, Fitbit, Garmin, and Oura Ring.

Wearable SpO₂ vs. Hospital Pulse Oximetry: Interpreting the Accuracy Gap

A clinical-grade finger pulse oximeter (the clip-on device used in hospitals and available at pharmacies) is more accurate than a wrist-worn PPG sensor for two reasons: better tissue contact and a more stable light path through the finger’s vascular bed.

For most healthy adults, the difference is clinically negligible — typically within 1–2 percentage points. For borderline readings or individuals with darker skin tones, that gap can matter.

Confirm any wearable SpO₂ reading that concerns you with a finger pulse oximeter before making any medical decision.

When Low Oxygen Is Concerning

Readings consistently below 90–92% (hypoxemia) may be concerning and warrant medical evaluation. However, consumer SpO₂ sensors are often less accurate than clinical pulse oximeters, particularly during movement or in individuals with darker skin tones or poor peripheral circulation.

CDC: pulse oximetry limitations and accuracy

Apple Watch vs. Garmin vs. Fitbit vs. Oura Ring: Accuracy Comparison by Metric

Which wearable gives you the most accurate heart health data? It depends on which metric matters most to you — and what you’re planning to do with the data.

This comparison is based on published accuracy studies, FDA clearance records, and manufacturer-disclosed validation data as of 2026. It reflects the most clinically meaningful accuracy differences across the four most widely owned consumer health wearables.

Side-by-Side Accuracy: HR, HRV, ECG, BP, SpO₂

Accuracy ranges are drawn from published validation studies and manufacturer data. Individual accuracy varies with device fit, skin tone, movement, and skin perfusion.

Which Device Has FDA 510(k) Clearance for Which Feature?

FDA clearance indicates a device has been reviewed for safety and effectiveness for a specific clinical application. It does not guarantee the same accuracy as a hospital device.

Kardia Mobile (AliveCor) is not a wrist wearable but remains the most FDA-validated consumer ECG device available and is recommended by many cardiologists for home AFib monitoring.

Key takeaway:

If ECG accuracy and AFib detection are your primary concern, Apple Watch (Series 4 or later) or Kardia Mobile offer the strongest FDA-validated performance.

If HRV accuracy and overnight physiological tracking matter most, Oura Ring’s form factor and measurement methodology offer meaningful advantages over wrist-based competitors.

When to Go to the ER Based on Your Smartwatch Reading

Seek emergency care immediately if your wearable shows any of the following alongside symptoms (chest pain, dizziness, shortness of breath, or fainting): heart rate above 150 bpm at rest, SpO₂ below 90% for more than 5 minutes, blood pressure above 180/120 mmHg, or an AFib alert with accompanying chest pain or dizziness.

A wearable alert is not a diagnosis. But some combinations of readings and symptoms require emergency action — and this section tells you exactly what those are.

The rule: symptoms always override numbers. If you feel chest pain, sudden dizziness, severe shortness of breath, or near-fainting — call 911. Don’t wait to check your wearable. Don’t drive yourself to the hospital.

Emergency Thresholds by Metric: Call 911 vs. See a Doctor vs. Monitor

Symptom Combinations That Require Immediate Action

Call 911 immediately — regardless of what your wearable shows — if you experience any of the following:

• Chest pain or pressure (with or without a wearable alert)
• Shortness of breath at rest that is new or worsening
• Sudden dizziness, lightheadedness, or fainting
• Sudden weakness or numbness in your face, arm, or leg
• Palpitations accompanied by near-fainting or sustained at rest for more than 30 minutes
• SpO₂ reading below 90% on your wearable confirmed with a pharmacy pulse oximeter

A wearable alert without any symptoms can typically be followed up with a physician visit within 24–48 hours. When in doubt — call your physician’s office or 911. Your wearable is a prompt, not a diagnosis.

Medical Accuracy Commitment

We review this content quarterly against current clinical guidelines. Found an error or have clinical feedback? [ Report a medical accuracy concern]

Not sure what your reading means? Here’s your decision framework.

This guide provides clinical context — it does not replace a personalized medical evaluation. If a reading concerned you, use the tiered framework below to determine your next step.

How to decide what to do next:

• Reading within normal ranges above + no symptoms → Monitor for 48–72 hours. If it normalizes, no action needed. If it persists, note it for your next routine physician visit.
• Reading borderline or outside normal ranges + no symptoms → Schedule a physician visit within 1–2 weeks. Bring your wearable or a screenshot of your data history.
• Reading at or beyond emergency thresholds + any symptoms → Call 911 or go to an emergency room immediately. Do not drive yourself.

Emergency symptoms that require immediate action regardless of wearable reading: Chest pain or pressure, shortness of breath at rest, sudden dizziness or fainting, new arm or jaw pain, sudden confusion or slurred speech.

References & Sources

• U.S. Food & Drug Administration (FDA). (n.d.). Pulse Oximeter Basics
• American Heart Association (AHA). (2024). Understanding Blood Pressure Readings.
• American Heart Association (AHA). (2024). All About Heart Rate (Pulse).
• Harvard Health Publishing. (2017). Heart rate variability: A new way to track well-being.
• Mayo Clinic. (2023). Blood pressure chart: What your reading means.
• Centers for Disease Control and Prevention (CDC). (n.d.). Clinical Care Guidance: Management and Treatment (Pulse oximetry considerations).

SCOPE & INTENDED USE

This page explains what common wearable heart health metrics measure, how consumer devices generate these measurements, and when readings may warrant clinical attention. Content is educational and non-diagnostic. It does not diagnose, treat, or manage medical conditions. Intended audience: adults 18+ using consumer wearables for wellness tracking.

Medical review and device testing methodology

See our medical review process